INTRODUCTION AND HYPOTHESIS: The aim of this study was to evaluate the effectiveness and overall safety of the Ajust Adjustable Single-Incision Sling in the treatment of female stress urinary incontinence. METHODS: This was a prospective, multicenter study conducted in women diagnosed with stress urinary incontinence. The Ajust Sling was implanted and patients were followed postoperatively for up to 29 months. Evaluations were performed to assess postoperative rate of continence, complications, and patient quality of life (QOL). RESULTS: From November 2008 through May 2009, 52 patients were enrolled and underwent a procedure to implant the Ajust Sling. Overall, 86.3 % of the patients who successfully received the Ajust Sling demonstrated total restoration or improvement of continence at the last study visit. QOL scores related to global bladder feeling and lifestyle improved. Only one patient reported the occurrence of mild pain which resolved without treatment or sequelae. CONCLUSIONS: In long-term follow-up, the Ajust Sling was safe and effective, restoring or improving continence in 86.3 % of patients.
INTRODUCTION AND HYPOTHESIS: The aim of this study was to evaluate the effectiveness and overall safety of the Ajust Adjustable Single-Incision Sling in the treatment of female stress urinary incontinence. METHODS: This was a prospective, multicenter study conducted in women diagnosed with stress urinary incontinence. The Ajust Sling was implanted and patients were followed postoperatively for up to 29 months. Evaluations were performed to assess postoperative rate of continence, complications, and patient quality of life (QOL). RESULTS: From November 2008 through May 2009, 52 patients were enrolled and underwent a procedure to implant the Ajust Sling. Overall, 86.3 % of the patients who successfully received the Ajust Sling demonstrated total restoration or improvement of continence at the last study visit. QOL scores related to global bladder feeling and lifestyle improved. Only one patient reported the occurrence of mild pain which resolved without treatment or sequelae. CONCLUSIONS: In long-term follow-up, the Ajust Sling was safe and effective, restoring or improving continence in 86.3 % of patients.
Authors: Bernard T Haylen; Robert M Freeman; Steven E Swift; Michel Cosson; G Willy Davila; Jan Deprest; Peter L Dwyer; Brigitte Fatton; Ervin Kocjancic; Joseph Lee; Chris Maher; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer; Ralph Webb Journal: Neurourol Urodyn Date: 2011-01 Impact factor: 2.696
Authors: Lauren A Cadish; Michele R Hacker; Laura E Dodge; Patricia Dramitinos; Lekha S Hota; Eman A Elkadry Journal: Am J Obstet Gynecol Date: 2010-08-21 Impact factor: 8.661
Authors: Karl Tamussino; Engelbert Hanzal; Dieter Kölle; Ayman Tammaa; Oliver Preyer; Wolfgang Umek; Vesna Bjelic-Radisic; Hermann Enzelsberger; Peter F J Lang; George Ralph; Paul Riss Journal: Am J Obstet Gynecol Date: 2007-12 Impact factor: 8.661
Authors: Allen F Morey; Andrew R Medendorp; Mark W Noller; Rafael V Mora; Kevin C Shandera; John P Foley; Luis R Rivera; Juan A Reyna; Patricia J Terry Journal: J Urol Date: 2006-03 Impact factor: 7.450
Authors: Matthew D Barber; Steven Kleeman; Mickey M Karram; Marie Fidela R Paraiso; Mark D Walters; Sandip Vasavada; Mark Ellerkmann Journal: Obstet Gynecol Date: 2008-03 Impact factor: 7.661
Authors: Jordi Sabadell; Marta Palau-Gené; Eva Huguet; Anabel Montero-Armengol; Sabina Salicrú; Jose L Poza Journal: Int Urogynecol J Date: 2016-12-05 Impact factor: 2.894
Authors: Ralf Anding; Manuel Schoen; Ruth Kirschner-Hermanns; Christian Fisang; Stefan C Müller; Stefan Latz Journal: Int Braz J Urol Date: 2017-01-27 Impact factor: 1.541